Kaman Reports Third Quarter 2022 Results
Kaman Corp. (NYSE:KAMN) reported third-quarter 2022 net sales of $172 million with a gross margin of 32.5%, but net earnings decreased to $0.6 million. The acquisition of Parker-Hannifin's Aircraft Wheel & Brake division is the largest in company history, aimed at enhancing product offerings and driving cash flow. Engineered Products showed a 9% growth year-over-year, while Precision Products faced delays impacting cash flow, pushing significant receipts to 2023. Adjusted EBITDA stood at $20.6 million, with a margin of 12%. Full-year guidance revised down due to program challenges.
- Acquisition of Parker-Hannifin's Aircraft Wheel & Brake division expands product offerings.
- Engineered Products segment growth of 9% year-over-year and strong order rates.
- Backlog increased organically by nearly 40% since the beginning of the year.
- Net earnings declined to $0.6 million compared to $4.1 million in the previous quarter.
- Significant delays in Precision Products affecting cash receipts pushed to 2023.
- Expected earnings and cash flow weakened in the Structures segment due to program and supplier challenges.
Third Quarter 2022 Highlights:
- Completed acquisition of Parker-Hannifin's Aircraft Wheel & Brake division, the largest in the history of the company
- Consolidated results supported by strength in Engineered Products amid program and supplier challenges
-
Net sales:
$172 million -
Gross Margin:
32.5% -
Net earnings:
$0.6 million -
Adjusted EBITDA*:
; Adjusted EBITDA margin*:$20.6 million 12.0% -
Diluted earnings per share:
per share,$0.02 per share adjusted*$0.32
Table 1. Summary of Financial Results (unaudited) |
|
|
|
|
||||||||||||||||
Thousands of (except share data) |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
|
$ |
172,004 |
|
|
$ |
160,766 |
|
|
$ |
179,836 |
|
|
$ |
490,818 |
|
|
$ |
533,846 |
|
Net earnings |
|
|
625 |
|
|
|
4,064 |
|
|
|
14,667 |
|
|
|
8,717 |
|
|
|
34,507 |
|
Adjusted EBITDA* |
|
|
20,614 |
|
|
|
16,429 |
|
|
|
27,816 |
|
|
|
49,229 |
|
|
|
71,873 |
|
Adjusted EBITDA margin* |
|
|
12.0 |
% |
|
|
10.2 |
% |
|
|
15.5 |
% |
|
|
10.0 |
% |
|
|
13.5 |
% |
Diluted earnings per share |
|
$ |
0.02 |
|
|
$ |
0.14 |
|
|
$ |
0.53 |
|
|
$ |
0.31 |
|
|
$ |
1.24 |
|
Adjusted diluted earnings per share* |
|
$ |
0.32 |
|
|
$ |
0.31 |
|
|
$ |
0.60 |
|
|
$ |
0.77 |
|
|
$ |
1.45 |
|
*See the end of this release for an explanation of the Company's use of Adjusted EBITDA, Adjusted EBITDA margin, Free cash flow and Adjusted diluted earnings per share. See tables 6-13 for reconciliations to the most comparable GAAP measure.
“In September, we executed on our growth strategy with the acquisition of Parker-Hannifin’s Aircraft Wheel and Brake division, the largest in our company's history. This acquisition expands the breadth of our product offerings and will drive meaningful margin and cash flow accretion. During the quarter, consolidated results benefited from strong performance in Engineered Products while some program and supplier challenges pressured current results and full year expectations. We continue to see strength in market demand with healthy order rates for our most profitable bearings, springs, seals and contacts products. In addition, demand in the commercial aerospace market is ramping, as sales increased to Boeing and Airbus for the fifth quarter in a row,” said
“In the third quarter, our Engineered Products segment delivered excellent performance with year over year sales growth of
“In Precision Products, our fuze delivery plan is slightly below our prior expectations due to a delay in receipt of a supplied component. This has shifted the timing of deliveries, which will postpone a significant portion of our cash receipts to 2023. With regard to our air vehicles program, we are excited to announce that the
“In our Structures segment, certain program and supplier challenges are delaying the recovery we had anticipated, impacting our expected earnings and cash flow performance for the full year. We remain focused on improving the operational performance of this segment and winning new business opportunities in complex structural programs,” said Walsh.
Outlook
"Kaman is seeing sustained strength in our backlog of greater than
"Over the long term, Kaman is positioned to provide meaningful shareholder returns. We will remain disciplined in our approach to capital allocation and our main priority is to deleverage our balance sheet. We will continue to invest in research and development of new products and remain thoughtful in our strategy to achieve top quartile EBITDA margin, free cash flow and return on invested capital,” Walsh said.
See Table 5 of this release for an updated outlook summary for 2022.
KAMAN BUSINESS RESULTS DISCUSSION
Kaman manages its portfolio through three segments: (1) Engineered Products; (2) Precision Products; and (3) Structures.
Engineered Products - Our Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated, proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters, fixed-wing and UAV aircraft.
Table 2. Engineered Products Results |
|
|
|
|
|
|
||||||||||||||
Thousands of |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
|
$ |
92,052 |
|
|
$ |
89,765 |
|
|
$ |
84,399 |
|
|
$ |
263,269 |
|
|
$ |
235,134 |
|
Operating income |
|
|
14,156 |
|
|
|
15,467 |
|
|
|
14,931 |
|
|
|
40,665 |
|
|
|
29,595 |
|
Adjusted EBITDA |
|
|
21,772 |
|
|
|
21,614 |
|
|
|
21,488 |
|
|
|
60,655 |
|
|
|
49,321 |
|
Adjusted EBITDA margin |
|
|
23.7 |
% |
|
|
24.1 |
% |
|
|
25.5 |
% |
|
|
23.0 |
% |
|
|
21.0 |
% |
Three months ended
Three months ended
Precision Products - Our Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the
Table 3. Precision Products Results |
|
|
|
|
|
|
||||||||||||||
Thousands of |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
|
$ |
46,282 |
|
|
$ |
41,267 |
|
|
$ |
63,584 |
|
|
$ |
135,098 |
|
|
$ |
195,656 |
|
Operating income |
|
|
5,730 |
|
|
|
2,550 |
|
|
|
13,792 |
|
|
|
11,689 |
|
|
|
46,274 |
|
Adjusted EBITDA |
|
|
6,534 |
|
|
|
3,593 |
|
|
|
14,814 |
|
|
|
14,567 |
|
|
|
49,381 |
|
Adjusted EBITDA margin |
|
|
14.1 |
% |
|
|
8.7 |
% |
|
|
23.3 |
% |
|
|
10.8 |
% |
|
|
25.2 |
% |
Three months ended
Three months ended
Structures - Our Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.
Table 4. Structures Results |
|
|
|
|
|
|
||||||||||||||
Thousands of |
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales |
|
$ |
33,670 |
|
|
$ |
29,734 |
|
|
$ |
31,853 |
|
|
$ |
92,451 |
|
|
$ |
103,056 |
|
Operating income (loss) |
|
|
71 |
|
|
|
(830 |
) |
|
|
330 |
|
|
|
(1,376 |
) |
|
|
(871 |
) |
Adjusted EBITDA |
|
|
941 |
|
|
|
57 |
|
|
|
1,187 |
|
|
|
1,287 |
|
|
|
1,702 |
|
Adjusted EBITDA margin |
|
|
2.8 |
% |
|
|
0.2 |
% |
|
|
3.7 |
% |
|
|
1.4 |
% |
|
|
1.7 |
% |
Three months ended
Three months ended
Please see the MD&A section of the Company's Form 10-Q filed with the
OUTLOOK
Table 5. Outlook |
|||||||
Millions of |
2022 Outlook |
||||||
|
Low End |
|
High End |
||||
|
$ |
695.0 |
|
|
$ |
710.0 |
|
Earnings from continuing operations |
$ |
12.1 |
|
|
$ |
16.3 |
|
Adjusted EBITDA |
$ |
72.5 |
|
|
$ |
77.5 |
|
Adjusted EBITDA margin |
|
10.4 |
% |
|
|
10.9 |
% |
Adjusted diluted earnings per share |
$ |
0.95 |
|
|
$ |
1.10 |
|
Cash flow from operating activities |
$ |
15.0 |
|
|
$ |
30.0 |
|
Adjusted free cash flow |
$ |
(10.0 |
) |
|
$ |
5.0 |
|
Please see the supplemental presentation relating to the third quarter 2022 on our Company's website for a full outlook summary.
CONFERENCE CALL
A webcast and conference call has been scheduled for tomorrow,
ABOUT
NON-GAAP MEASURES DISCLOSURE
Management believes that the Non-GAAP financial measures (i.e. financial measures that are not computed in accordance with Generally Accepted Accounting Principles) used in this release or in other disclosures provide important perspectives into the Company's ongoing business performance. The Company does not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the Non-GAAP measures used in this release and other disclosures as follows:
Adjusted EBITDA and Adjusted EBITDA margin - Adjusted EBITDA for the consolidated company results is defined as net earnings before interest, taxes, other expense (income), net, depreciation and amortization and certain items that are not indicative of the operating performance of the Company for the periods presented. Adjusted EBITDA for the segments is defined as operating income before depreciation and amortization. Adjusted EBITDA margin is defined as Adjusted EBITDA as a percent of Net sales. Management believes Adjusted EBITDA and Adjusted EBITDA margin provide an additional perspective on the operating results of the organization and its earnings capacity and helps improve the comparability of our results between periods because they provide a view of our operations that excludes items that management believes are not reflective of operating performance, such as items traditionally removed from net earnings in the calculation of EBITDA as well as Other expense (income), net and certain items that are not indicative of the operating performance of the Company for the period presented. Adjusted EBITDA and Adjusted EBITDA margin are not presented as an alternative measure of operating performance, as determined in accordance with GAAP. The following tables illustrate the calculation of Adjusted EBITDA:
Table 6. Adjusted EBITDA and Adjusted EBITDA Margin (unaudited) |
|
|
|
|
||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
Thousands of |
|
|
||||||||||||||||||
|
|
Consolidated |
|
Engineered Products |
|
Precision Products |
|
Structures |
|
Corp/Elims** |
||||||||||
Net sales |
|
$ |
172,004 |
|
|
$ |
92,052 |
|
|
$ |
46,282 |
|
|
$ |
33,670 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net earnings |
|
|
625 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense, net |
|
|
3,614 |
|
|
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
|
|
128 |
|
|
|
|
|
|
|
|
|
||||||||
Non-service pension and post retirement benefit income |
|
|
(5,142 |
) |
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
|
1,221 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
$ |
446 |
|
|
$ |
14,156 |
|
|
$ |
5,730 |
|
|
$ |
71 |
|
|
$ |
(19,511 |
) |
Depreciation and amortization |
|
|
9,383 |
|
|
|
6,856 |
|
|
|
804 |
|
|
|
870 |
|
|
|
853 |
|
Restructuring and severance costs |
|
|
(243 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(243 |
) |
Cost associated with corporate development activities |
|
|
10,725 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
10,725 |
|
Inventory step-up associated with acquisition |
|
|
760 |
|
|
|
760 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(457 |
) |
Other Adjustments |
|
$ |
20,168 |
|
|
$ |
7,616 |
|
|
$ |
804 |
|
|
$ |
870 |
|
|
$ |
10,878 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
$ |
20,614 |
|
|
$ |
21,772 |
|
|
$ |
6,534 |
|
|
$ |
941 |
|
|
$ |
(8,633 |
) |
Adjusted EBITDA margin |
|
|
12.0 |
% |
|
|
23.7 |
% |
|
|
14.1 |
% |
|
|
2.8 |
% |
|
|
**Corp/Elims Operating income (loss) represents the Corporate office expenses and
Table 7. Adjusted EBITDA and Adjusted EBITDA margin (unaudited) |
|
|
|
|
||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
Thousands of |
|
|
||||||||||||||||||
|
|
Consolidated |
|
Engineered Products |
|
Precision Products |
|
Structures |
|
Corp/Elims** |
||||||||||
Net sales |
|
$ |
160,766 |
|
|
$ |
89,765 |
|
|
$ |
41,267 |
|
|
$ |
29,734 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net earnings |
|
|
4,064 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense, net |
|
|
1,993 |
|
|
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
|
|
557 |
|
|
|
|
|
|
|
|
|
||||||||
Non-service pension and post retirement benefit income |
|
|
(5,024 |
) |
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
|
690 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
$ |
2,280 |
|
|
$ |
15,467 |
|
|
$ |
2,550 |
|
|
$ |
(830 |
) |
|
$ |
(14,907 |
) |
Depreciation and amortization |
|
|
8,822 |
|
|
|
6,147 |
|
|
|
1,043 |
|
|
|
887 |
|
|
|
745 |
|
Restructuring and severance costs |
|
|
2,927 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,927 |
|
Cost associated with corporate development activities |
|
|
2,400 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,400 |
|
Other Adjustments |
|
$ |
14,149 |
|
|
$ |
6,147 |
|
|
$ |
1,043 |
|
|
$ |
887 |
|
|
$ |
6,072 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
$ |
16,429 |
|
|
$ |
21,614 |
|
|
$ |
3,593 |
|
|
$ |
57 |
|
|
$ |
(8,835 |
) |
Adjusted EBITDA margin |
|
|
10.2 |
% |
|
|
24.1 |
% |
|
|
8.7 |
% |
|
|
0.2 |
% |
|
|
**Corp/Elims Operating income (loss) represents the Corporate office expenses and
Table 8. Adjusted EBITDA and Adjusted EBITDA margin (unaudited) |
|
|
|
|
||||||||||||||||
|
|
Three Months Ended |
||||||||||||||||||
Thousands of |
|
|
||||||||||||||||||
|
|
Consolidated |
|
Engineered Products |
|
Precision Products |
|
Structures |
|
Corp/Elims** |
||||||||||
Net sales |
|
$ |
179,836 |
|
|
$ |
84,399 |
|
|
$ |
63,584 |
|
|
$ |
31,853 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net earnings |
|
|
14,667 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense, net |
|
|
3,646 |
|
|
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
|
|
4,447 |
|
|
|
|
|
|
|
|
|
||||||||
Non-service pension and post retirement benefit income |
|
|
(6,612 |
) |
|
|
|
|
|
|
|
|
||||||||
Income from |
|
|
(14 |
) |
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
|
(172 |
) |
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
$ |
15,962 |
|
|
$ |
14,931 |
|
|
$ |
13,792 |
|
|
$ |
330 |
|
|
$ |
(13,091 |
) |
Depreciation and amortization |
|
|
9,083 |
|
|
|
6,557 |
|
|
|
1,022 |
|
|
|
857 |
|
|
|
647 |
|
Restructuring and severance costs |
|
|
2,611 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,611 |
|
Costs associated with corporate development activities |
|
|
136 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
136 |
|
Costs from transition service agreement |
|
|
24 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
24 |
|
Other Adjustments |
|
$ |
11,854 |
|
|
$ |
6,557 |
|
|
$ |
1,022 |
|
|
$ |
857 |
|
|
$ |
3,418 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
$ |
27,816 |
|
|
$ |
21,488 |
|
|
$ |
14,814 |
|
|
$ |
1,187 |
|
|
$ |
(9,673 |
) |
Adjusted EBITDA margin |
|
|
15.5 |
% |
|
|
25.5 |
% |
|
|
23.3 |
% |
|
|
3.7 |
% |
|
|
**Corp/Elims Operating income (loss) represents the Corporate office expenses and
Table 9. Adjusted EBITDA and Adjusted EBITDA margin (unaudited) |
|
|
|
|
||||||||||||||||
|
|
Nine Months Ended |
||||||||||||||||||
Thousands of |
|
|
||||||||||||||||||
|
|
Consolidated |
|
Engineered Products |
|
Precision Products |
|
Structures |
|
Corp/Elims** |
||||||||||
Net sales |
|
$ |
490,818 |
|
|
$ |
263,269 |
|
|
$ |
135,098 |
|
|
$ |
92,451 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net earnings |
|
|
8,717 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense, net |
|
|
8,088 |
|
|
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
|
|
1,992 |
|
|
|
|
|
|
|
|
|
||||||||
Non-service pension and post retirement benefit income |
|
|
(15,429 |
) |
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
|
2,415 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
$ |
5,783 |
|
|
$ |
40,665 |
|
|
$ |
11,689 |
|
|
$ |
(1,376 |
) |
|
$ |
(45,195 |
) |
Depreciation and amortization |
|
|
27,037 |
|
|
|
19,230 |
|
|
|
2,878 |
|
|
|
2,663 |
|
|
|
2,266 |
|
Restructuring and severance costs |
|
|
2,853 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,853 |
|
Cost associated with corporate development activities |
|
|
13,253 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
13,253 |
|
Inventory step-up associated with acquisition |
|
|
760 |
|
|
|
760 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(457 |
) |
Other Adjustments |
|
$ |
43,446 |
|
|
$ |
19,990 |
|
|
$ |
2,878 |
|
|
$ |
2,663 |
|
|
$ |
17,915 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
$ |
49,229 |
|
|
$ |
60,655 |
|
|
$ |
14,567 |
|
|
$ |
1,287 |
|
|
$ |
(27,280 |
) |
Adjusted EBITDA margin |
|
|
10.0 |
% |
|
|
23.0 |
% |
|
|
10.8 |
% |
|
|
1.4 |
% |
|
|
**Corp/Elims Operating income (loss) represents the Corporate office expenses and
Table 10. Adjusted EBITDA and Adjusted EBITDA margin (unaudited) |
|
|
|
|
||||||||||||||||
|
|
Nine Months Ended |
||||||||||||||||||
Thousands of |
|
|
||||||||||||||||||
|
|
Consolidated |
|
Engineered Products |
|
Precision Products |
|
Structures |
|
Corp/Elims** |
||||||||||
Net sales |
|
$ |
533,846 |
|
|
$ |
235,134 |
|
|
$ |
195,656 |
|
|
$ |
103,056 |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net earnings |
|
$ |
34,507 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Interest expense, net |
|
|
12,232 |
|
|
|
|
|
|
|
|
|
||||||||
Income tax expense (benefit) |
|
|
10,156 |
|
|
|
|
|
|
|
|
|
||||||||
Non-service pension and post retirement benefit income |
|
|
(19,832 |
) |
|
|
|
|
|
|
|
|
||||||||
Income from |
|
|
(931 |
) |
|
|
|
|
|
|
|
|
||||||||
Other expense (income), net |
|
|
275 |
|
|
|
|
|
|
|
|
|
||||||||
Operating income (loss) |
|
$ |
36,407 |
|
|
$ |
29,595 |
|
|
$ |
46,274 |
|
|
$ |
(871 |
) |
|
$ |
(38,591 |
) |
Depreciation and amortization |
|
|
27,474 |
|
|
|
19,726 |
|
|
|
3,107 |
|
|
|
2,573 |
|
|
|
2,068 |
|
Restructuring and severance costs |
|
|
5,479 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
5,479 |
|
Costs from transition service agreement |
|
|
1,728 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,728 |
|
Cost associated with corporate development activities |
|
|
551 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
551 |
|
(Gain) loss on sale of business |
|
|
234 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
234 |
|
Other Adjustments |
|
$ |
35,466 |
|
|
$ |
19,726 |
|
|
$ |
3,107 |
|
|
$ |
2,573 |
|
|
$ |
10,060 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted EBITDA |
|
$ |
71,873 |
|
|
$ |
49,321 |
|
|
$ |
49,381 |
|
|
$ |
1,702 |
|
|
$ |
(28,531 |
) |
Adjusted EBITDA margin |
|
|
13.5 |
% |
|
|
21.0 |
% |
|
|
25.2 |
% |
|
|
1.7 |
% |
|
|
**Corp/Elims Operating income (loss) represents the Corporate office expenses and
Adjusted Net Earnings and Adjusted Diluted Earnings Per Share - Adjusted net earnings and adjusted diluted earnings per share are defined as GAAP "Net earnings" and "Diluted earnings per share", less items that are not indicative of the operating performance of the business for the periods presented. Management uses adjusted net earnings and adjusted diluted earnings per share to evaluate performance period over period, to analyze the underlying trends in our business and to assess its performance relative to its competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance. The following table illustrates the calculation of adjusted net earnings and adjusted diluted earnings per share:
Table 11. Adjusted Net Earnings and Adjusted Diluted Earnings per Share (unaudited) |
|||||||||||||||||||||||
Thousands of |
|
|
|
|
|
|
|||||||||||||||||
|
|
Three Months Ended |
|
Three Months Ended |
|||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||
|
|
Pre-Tax |
|
Tax-Effected |
|
Diluted EPS |
|
Pre-Tax |
|
Tax-Effected |
|
Diluted EPS |
|||||||||||
Net earnings |
|
$ |
753 |
|
|
$ |
625 |
|
|
$ |
0.02 |
|
|
$ |
19,114 |
|
|
$ |
14,667 |
|
|
$ |
0.53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring and severance costs |
|
|
(243 |
) |
|
|
(189 |
) |
|
|
(0.01 |
) |
|
|
2,611 |
|
|
|
2,003 |
|
|
|
0.07 |
Costs associated with corporate development activities |
|
|
10,725 |
|
|
|
8,363 |
|
|
|
0.30 |
|
|
|
136 |
|
|
|
104 |
|
|
|
— |
Inventory step-up associated with acquisition |
|
|
760 |
|
|
|
593 |
|
|
|
0.02 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
Costs from transition services agreement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
24 |
|
|
|
18 |
|
|
|
— |
Income from transition services agreement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(14 |
) |
|
|
(11 |
) |
|
|
— |
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
(356 |
) |
|
|
(0.01 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
Adjustments |
|
$ |
10,785 |
|
|
$ |
8,411 |
|
|
$ |
0.30 |
|
|
$ |
2,757 |
|
|
$ |
2,114 |
|
|
$ |
0.07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted net earnings |
|
$ |
11,538 |
|
|
$ |
9,036 |
|
|
$ |
0.32 |
|
|
$ |
21,871 |
|
|
$ |
16,781 |
|
|
$ |
0.60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted weighted average shares outstanding |
|
|
|
|
|
|
28,088 |
|
|
|
|
|
|
|
27,888 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
Three Months Ended |
|||||||||||||||
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
|
|
|
|
|
|
|
Pre-Tax |
|
Tax-Effected |
|
Diluted EPS |
|||||||||||
Net earnings |
|
$ |
4,621 |
|
|
$ |
4,064 |
|
|
$ |
0.14 |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Restructuring and severance costs |
|
|
2,927 |
|
|
|
2,574 |
|
|
|
0.09 |
||||||||||||
Costs associated with corporate development activities |
|
|
2,400 |
|
|
|
2,111 |
|
|
|
0.08 |
||||||||||||
Adjustments |
|
$ |
5,327 |
|
|
$ |
4,685 |
|
|
$ |
0.17 |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted net earnings |
|
$ |
9,948 |
|
|
$ |
8,749 |
|
|
$ |
0.31 |
||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
Diluted weighted average shares outstanding |
|
|
|
|
|
|
28,059 |
Table 12. Adjusted Net Earnings and Adjusted Diluted Earnings per Share (unaudited) |
||||||||||||||||||||||||
Thousands of |
|
|
|
|
|
|
||||||||||||||||||
|
|
Nine Months Ended |
|
Nine Months Ended |
||||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||
|
|
Pre-Tax |
|
Tax-Effected |
|
Diluted EPS |
|
Pre-Tax |
|
Tax-Effected |
|
Diluted EPS |
||||||||||||
Net earnings |
|
$ |
10,709 |
|
|
$ |
8,717 |
|
|
$ |
0.31 |
|
|
$ |
44,663 |
|
|
$ |
34,507 |
|
|
$ |
1.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Restructuring and severance costs |
|
|
2,853 |
|
|
|
2,225 |
|
|
|
0.08 |
|
|
|
5,479 |
|
|
|
4,280 |
|
|
|
0.15 |
|
Costs associated with corporate development activities |
|
|
13,253 |
|
|
|
10,334 |
|
|
|
0.37 |
|
|
|
551 |
|
|
|
432 |
|
|
|
0.02 |
|
Inventory step-up associated with acquisition |
|
|
760 |
|
|
|
593 |
|
|
|
0.02 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Costs from transition services agreement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,728 |
|
|
|
1,370 |
|
|
|
0.05 |
|
Income from transition services agreement |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(931 |
) |
|
|
(739 |
) |
|
|
(0.03 |
) |
Tax expense on sale of |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
287 |
|
|
|
287 |
|
|
|
0.01 |
|
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
(356 |
) |
|
|
(0.01 |
) |
|
|
234 |
|
|
|
234 |
|
|
|
0.01 |
|
Adjustments |
|
$ |
16,409 |
|
|
$ |
12,796 |
|
|
$ |
0.46 |
|
|
$ |
7,348 |
|
|
$ |
5,864 |
|
|
$ |
0.21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Adjusted net earnings |
|
$ |
27,118 |
|
|
$ |
21,513 |
|
|
$ |
0.77 |
|
|
$ |
52,011 |
|
|
$ |
40,371 |
|
|
$ |
1.45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Diluted weighted average shares outstanding |
|
|
|
|
|
|
28,076 |
|
|
|
|
|
|
|
27,889 |
|
Free Cash Flow - Free cash flow is defined as GAAP “Net cash provided by (used in) operating activities” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes free cash flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free cash flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions. Management uses free cash flow internally to assess overall liquidity. The following table illustrates the calculation of free cash flow.
Table 13. Free Cash Flow (unaudited) |
||||||||||||||||||||
Thousands of |
|
Three Months Ended |
|
Last Twelve Months |
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net cash provided by (used in) operating activities |
|
$ |
34,575 |
|
|
$ |
(1,017 |
) |
|
$ |
(25,937 |
) |
|
$ |
(6,746 |
) |
|
$ |
875 |
|
Expenditures for property, plant & equipment |
|
|
(6,166 |
) |
|
|
(6,877 |
) |
|
|
(3,643 |
) |
|
|
(7,106 |
) |
|
|
(23,792 |
) |
Free cash flow |
|
$ |
28,409 |
|
|
$ |
(7,894 |
) |
|
$ |
(29,580 |
) |
|
$ |
(13,852 |
) |
|
$ |
(22,917 |
) |
FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; (ii) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of
Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(Thousands of
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
|
|
|
|
||||||||
Net sales |
|
$ |
172,004 |
|
|
$ |
179,836 |
|
|
$ |
490,818 |
|
|
$ |
533,846 |
|
Cost of sales |
|
|
116,179 |
|
|
|
116,771 |
|
|
|
332,299 |
|
|
|
355,930 |
|
Gross profit |
|
|
55,825 |
|
|
|
63,065 |
|
|
|
158,519 |
|
|
|
177,916 |
|
Selling, general and administrative expenses |
|
|
49,009 |
|
|
|
39,335 |
|
|
|
127,980 |
|
|
|
116,182 |
|
Research and development costs |
|
|
3,937 |
|
|
|
2,540 |
|
|
|
14,265 |
|
|
|
10,004 |
|
Intangible asset amortization expense |
|
|
3,118 |
|
|
|
2,624 |
|
|
|
8,024 |
|
|
|
7,898 |
|
Costs from transition services agreement |
|
|
— |
|
|
|
24 |
|
|
|
— |
|
|
|
1,728 |
|
Restructuring and severance costs |
|
|
(243 |
) |
|
|
2,611 |
|
|
|
2,853 |
|
|
|
5,479 |
|
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
— |
|
|
|
(457 |
) |
|
|
234 |
|
Net loss (gain) on sale of assets |
|
|
15 |
|
|
|
(31 |
) |
|
|
71 |
|
|
|
(16 |
) |
Operating income |
|
|
446 |
|
|
|
15,962 |
|
|
|
5,783 |
|
|
|
36,407 |
|
Interest expense, net |
|
|
3,614 |
|
|
|
3,646 |
|
|
|
8,088 |
|
|
|
12,232 |
|
Non-service pension and post retirement benefit income |
|
|
(5,142 |
) |
|
|
(6,612 |
) |
|
|
(15,429 |
) |
|
|
(19,832 |
) |
Income from transition services agreement |
|
|
— |
|
|
|
(14 |
) |
|
|
— |
|
|
|
(931 |
) |
Other income, net |
|
|
1,221 |
|
|
|
(172 |
) |
|
|
2,415 |
|
|
|
275 |
|
Net earnings before income taxes |
|
|
753 |
|
|
|
19,114 |
|
|
|
10,709 |
|
|
|
44,663 |
|
Income tax expense |
|
|
128 |
|
|
|
4,447 |
|
|
|
1,992 |
|
|
|
10,156 |
|
Net earnings |
|
$ |
625 |
|
|
$ |
14,667 |
|
|
$ |
8,717 |
|
|
$ |
34,507 |
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings per share: |
|
|
|
|
|
|
|
|
||||||||
Basic earnings per share |
|
$ |
0.02 |
|
|
$ |
0.53 |
|
|
$ |
0.31 |
|
|
$ |
1.24 |
|
Diluted earnings per share |
|
$ |
0.02 |
|
|
$ |
0.53 |
|
|
$ |
0.31 |
|
|
$ |
1.24 |
|
Average shares outstanding: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
28,037 |
|
|
|
27,882 |
|
|
|
27,997 |
|
|
|
27,855 |
|
Diluted |
|
|
28,088 |
|
|
|
27,888 |
|
|
|
28,076 |
|
|
|
27,889 |
|
KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(Thousands of
|
|
|
|
|
||||
Assets |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
31,358 |
|
|
$ |
140,800 |
|
Accounts receivable, net |
|
|
102,477 |
|
|
|
73,524 |
|
Contract assets |
|
|
117,828 |
|
|
|
112,354 |
|
Contract costs, current portion |
|
|
822 |
|
|
|
850 |
|
Inventories |
|
|
221,815 |
|
|
|
193,100 |
|
Income tax refunds receivable |
|
|
15,865 |
|
|
|
13,832 |
|
Other current assets |
|
|
15,749 |
|
|
|
12,083 |
|
Total current assets |
|
|
505,914 |
|
|
|
546,543 |
|
Property, plant and equipment, net of accumulated depreciation of |
|
|
198,866 |
|
|
|
197,822 |
|
Operating right-of-use assets, net |
|
|
7,523 |
|
|
|
11,011 |
|
|
|
|
390,734 |
|
|
|
240,681 |
|
Other intangible assets, net |
|
|
385,478 |
|
|
|
138,074 |
|
Deferred income taxes |
|
|
15,711 |
|
|
|
15,717 |
|
Contract costs, noncurrent portion |
|
|
9,865 |
|
|
|
10,249 |
|
Investment in Near Earth Autonomy |
|
|
10,000 |
|
|
|
— |
|
Other assets |
|
|
40,443 |
|
|
|
38,385 |
|
Total assets |
|
$ |
1,564,534 |
|
|
$ |
1,198,482 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable – trade |
|
$ |
37,267 |
|
|
$ |
42,134 |
|
Accrued salaries and wages |
|
|
31,952 |
|
|
|
38,892 |
|
Contract liabilities, current portion |
|
|
3,932 |
|
|
|
2,945 |
|
Operating lease liabilities, current portion |
|
|
3,633 |
|
|
|
4,502 |
|
Income taxes payable |
|
|
183 |
|
|
|
386 |
|
Other current liabilities |
|
|
38,404 |
|
|
|
32,076 |
|
Total current liabilities |
|
|
115,371 |
|
|
|
120,935 |
|
Long-term debt, excluding current portion, net of debt issuance costs |
|
|
609,800 |
|
|
|
189,421 |
|
Deferred income taxes |
|
|
6,194 |
|
|
|
6,506 |
|
Underfunded pension |
|
|
5,574 |
|
|
|
21,786 |
|
Contract liabilities, noncurrent portion |
|
|
20,477 |
|
|
|
16,528 |
|
Operating lease liabilities, noncurrent portion |
|
|
4,569 |
|
|
|
7,140 |
|
Other long-term liabilities |
|
|
35,940 |
|
|
|
39,837 |
|
Commitments and contingencies |
|
|
|
|
||||
Shareholders' equity: |
|
|
|
|
||||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
30,620 |
|
|
|
30,434 |
|
Additional paid-in capital |
|
|
243,330 |
|
|
|
248,153 |
|
Retained earnings |
|
|
749,007 |
|
|
|
750,445 |
|
Accumulated other comprehensive income (loss) |
|
|
(134,256 |
) |
|
|
(111,385 |
) |
Less 2,604,564 and 2,573,896 shares of common stock, respectively, held in treasury, at cost |
|
|
(122,092 |
) |
|
|
(121,318 |
) |
Total shareholders’ equity |
|
|
766,609 |
|
|
|
796,329 |
|
Total liabilities and shareholders’ equity |
|
$ |
1,564,534 |
|
|
$ |
1,198,482 |
|
|
|
|
|
|
||||
|
|
|
|
|
||||
|
|
|
|
|
KAMAN CORPORATION AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Thousands of
|
|
Nine Months Ended |
||||||
|
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net earnings |
|
$ |
8,717 |
|
|
$ |
34,507 |
|
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
27,037 |
|
|
|
27,474 |
|
Amortization of debt issuance costs |
|
|
1,882 |
|
|
|
1,406 |
|
Accretion of convertible notes discount |
|
|
— |
|
|
|
2,191 |
|
Provision for doubtful accounts |
|
|
619 |
|
|
|
373 |
|
(Gain) loss on sale of business |
|
|
(457 |
) |
|
|
234 |
|
Net loss (gain) on sale of assets |
|
|
71 |
|
|
|
(16 |
) |
Net loss on derivative instruments |
|
|
2,670 |
|
|
|
815 |
|
Stock compensation expense |
|
|
6,145 |
|
|
|
5,684 |
|
Non-cash consideration received for blade exchange |
|
|
(827 |
) |
|
|
— |
|
Deferred income taxes |
|
|
1,600 |
|
|
|
4,822 |
|
Changes in assets and liabilities, excluding effects of acquisitions/divestitures: |
|
|
|
|
||||
Accounts receivable |
|
|
(23,640 |
) |
|
|
71,434 |
|
Contract assets |
|
|
(5,405 |
) |
|
|
(19,940 |
) |
Contract costs |
|
|
452 |
|
|
|
(99 |
) |
Inventories |
|
|
(21,187 |
) |
|
|
(12,435 |
) |
Income tax refunds receivable |
|
|
(2,040 |
) |
|
|
3,145 |
|
Operating right of use assets |
|
|
3,347 |
|
|
|
1,739 |
|
Other assets |
|
|
(3,682 |
) |
|
|
1,042 |
|
Accounts payable - trade |
|
|
(8,780 |
) |
|
|
(21,829 |
) |
Contract liabilities |
|
|
4,246 |
|
|
|
(24,036 |
) |
Operating lease liabilities |
|
|
(3,296 |
) |
|
|
(1,810 |
) |
Acquired retention plan payments |
|
|
— |
|
|
|
(25,108 |
) |
Other current liabilities |
|
|
(4,591 |
) |
|
|
(2,698 |
) |
Income taxes payable |
|
|
(227 |
) |
|
|
1,173 |
|
Pension liabilities |
|
|
(13,309 |
) |
|
|
(29,256 |
) |
Other long-term liabilities |
|
|
(3,045 |
) |
|
|
(4,689 |
) |
Net cash used in operating activities |
|
|
(33,700 |
) |
|
|
14,123 |
|
Cash flows from investing activities: |
|
|
|
|
||||
Proceeds from sale of business, net of cash on hand |
|
|
1,200 |
|
|
|
(3,428 |
) |
Expenditures for property, plant & equipment |
|
|
(17,626 |
) |
|
|
(11,364 |
) |
Investment in Near Earth Autonomy |
|
|
(10,000 |
) |
|
|
— |
|
Acquisition of businesses |
|
|
(441,340 |
) |
|
|
— |
|
Other, net |
|
|
1,238 |
|
|
|
(502 |
) |
Net cash used in investing activities |
|
|
(466,528 |
) |
|
|
(15,294 |
) |
Cash flows from financing activities: |
|
|
|
|
||||
Net borrowings under revolving credit agreement |
|
|
412,000 |
|
|
|
— |
|
Purchase of treasury shares |
|
|
(762 |
) |
|
|
(459 |
) |
Dividends paid |
|
|
(16,760 |
) |
|
|
(16,672 |
) |
Debt issuance costs |
|
|
(4,285 |
) |
|
|
— |
|
Other, net |
|
|
1,725 |
|
|
|
4,086 |
|
Net cash provided by (used in) financing activities |
|
|
391,918 |
|
|
|
(13,045 |
) |
Net decrease in cash and cash equivalents |
|
|
(108,310 |
) |
|
|
(14,216 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(1,132 |
) |
|
|
(415 |
) |
Cash and cash equivalents and restricted cash at beginning of period |
|
|
140,800 |
|
|
|
136,089 |
|
Cash and cash equivalents and restricted cash at end of period |
|
$ |
31,358 |
|
|
$ |
121,458 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221031005752/en/
Investor Relations
(860) 243-7485
kary.bare@kaman.com
Source:
FAQ
What were Kaman Corp.'s Q3 2022 net sales and earnings?
How did the acquisition of Parker-Hannifin's Aircraft Wheel & Brake division impact Kaman?
What is Kaman's adjusted EBITDA for Q3 2022?
Why was Kaman's full-year guidance revised down?